POSTN
Basic information
Region (hg38): 13:37562583-37598844
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POSTN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 45 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 45 | 1 | 4 |
Variants in POSTN
This is a list of pathogenic ClinVar variants found in the POSTN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-37563343-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
13-37569335-A-G | Benign (Mar 01, 2023) | |||
13-37569359-A-G | not specified | Uncertain significance (Nov 21, 2022) | ||
13-37571407-A-T | not specified | Uncertain significance (May 30, 2024) | ||
13-37571423-G-A | not specified | Uncertain significance (May 09, 2023) | ||
13-37571428-C-T | not specified | Uncertain significance (Jul 14, 2023) | ||
13-37571432-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
13-37571450-G-C | not specified | Uncertain significance (Mar 27, 2023) | ||
13-37574601-C-T | not specified | Uncertain significance (Nov 12, 2021) | ||
13-37574635-T-G | not specified | Uncertain significance (Apr 28, 2023) | ||
13-37577776-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
13-37578860-T-G | not specified | Uncertain significance (Nov 22, 2023) | ||
13-37578894-C-A | not specified | Uncertain significance (Oct 10, 2023) | ||
13-37579087-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
13-37579121-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
13-37579312-C-G | not specified | Uncertain significance (Feb 05, 2024) | ||
13-37579350-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
13-37579355-G-T | not specified | Uncertain significance (Jan 31, 2022) | ||
13-37579938-G-A | not specified | Uncertain significance (Jun 26, 2023) | ||
13-37580595-G-A | not specified | Uncertain significance (May 27, 2022) | ||
13-37580660-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
13-37582377-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
13-37582490-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
13-37582506-G-C | not specified | Uncertain significance (Nov 18, 2023) | ||
13-37584026-C-G | not specified | Uncertain significance (Sep 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POSTN | protein_coding | protein_coding | ENST00000379747 | 23 | 36262 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.07e-9 | 0.999 | 125652 | 0 | 96 | 125748 | 0.000382 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.852 | 393 | 443 | 0.886 | 0.0000225 | 5479 |
Missense in Polyphen | 151 | 186.67 | 0.8089 | 2295 | ||
Synonymous | -0.617 | 166 | 156 | 1.06 | 0.00000850 | 1565 |
Loss of Function | 3.00 | 22 | 43.3 | 0.508 | 0.00000219 | 570 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000414 | 0.000401 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000282 | 0.000272 |
Finnish | 0.00158 | 0.00157 |
European (Non-Finnish) | 0.000314 | 0.000308 |
Middle Eastern | 0.000282 | 0.000272 |
South Asian | 0.000340 | 0.000327 |
Other | 0.000493 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Induces cell attachment and spreading and plays a role in cell adhesion (PubMed:12235007). Enhances incorporation of BMP1 in the fibronectin matrix of connective tissues, and subsequent proteolytic activation of lysyl oxidase LOX (By similarity). {ECO:0000250|UniProtKB:Q62009, ECO:0000269|PubMed:12235007}.;
- Pathway
- Hypothesized Pathways in Pathogenesis of Cardiovascular Disease;Amplification and Expansion of Oncogenic Pathways as Metastatic Traits
(Consensus)
Recessive Scores
- pRec
- 0.744
Intolerance Scores
- loftool
- 0.0534
- rvis_EVS
- 0.27
- rvis_percentile_EVS
- 70.58
Haploinsufficiency Scores
- pHI
- 0.933
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.514
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.198
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Postn
- Phenotype
- immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; neoplasm; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- skeletal system development;response to hypoxia;negative regulation of cell-matrix adhesion;regulation of systemic arterial blood pressure;cell adhesion;regulation of Notch signaling pathway;response to mechanical stimulus;response to muscle activity;positive regulation of smooth muscle cell migration;extracellular matrix organization;response to estradiol;cellular response to fibroblast growth factor stimulus;cellular response to vitamin K;cellular response to tumor necrosis factor;cellular response to transforming growth factor beta stimulus;negative regulation of substrate adhesion-dependent cell spreading;positive regulation of chemokine (C-C motif) ligand 2 secretion;neuron projection extension;bone regeneration
- Cellular component
- extracellular space;trans-Golgi network;extracellular matrix;neuromuscular junction;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent;protein binding;heparin binding;metal ion binding;cell adhesion molecule binding